Literature DB >> 15760868

Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology.

Jeroen J G Geurts1, Lars Bö, Petra J W Pouwels, Jonas A Castelijns, Chris H Polman, Frederik Barkhof.   

Abstract

BACKGROUND AND
PURPOSE: Cortical lesions constitute a substantial part of the total lesion load in multiple sclerosis (MS) brain. They have been related to neuropsychological deficits, epilepsy, and depression. However, the proportion of purely cortical lesions visible on MR images is unknown. The aim of this study was to determine the proportion of intracortical and mixed gray matter (GM)-white matter (WM) lesions that can be visualized with postmortem MR imaging.
METHODS: We studied 49 brain samples from nine cases of chronic MS. Tissue sections were matched to dual-echo T2-weighted spin-echo (T2SE) MR images. MS lesions were identified by means of myelin basic protein immunostaining, and lesions were classified as intracortical, mixed GM-WM, deep GM, or WM. Investigators blinded to the histopathologic results scored postmortem T2SE and 3D fluid-attenuated inversion recovery (FLAIR) images.
RESULTS: Immunohistochemistry confirmed 70 WM, eight deep GM, 27 mixed GM-WM, and 63 purely cortical lesions. T2SE images depicted only 3% of the intracortical lesions, and 3D FLAIR imaging showed 5%. Mixed GM-WM lesions were most frequently detectable on T2SE and 3D FLAIR images (22% and 41%, respectively). T2SE imaging showed 13% of deep GM lesions versus 38% on 3D FLAIR. T2SE images depicted 63% of the WM lesions, whereas 3D FLAIR images depicted 71%. Even after side-by-side review of the MR imaging and histopathologic results, many of the intracortical lesions could not be identified retrospectively.
CONCLUSION: In contrast to WM lesions and mixed GM-WM lesions, intracortical lesions remain largely undetected with current MR imaging resolution.

Entities:  

Mesh:

Year:  2005        PMID: 15760868      PMCID: PMC7976495     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  33 in total

1.  Neuropsychological impairment in multiple sclerosis patients: the role of (juxta)cortical lesion on FLAIR.

Authors:  R H Lazeron; D W Langdon; M Filippi; J H van Waesberghe; V L Stevenson; J B Boringa; D Origgi; A J Thompson; M Falautano; C H Polman; F Barkhof
Journal:  Mult Scler       Date:  2000-08       Impact factor: 6.312

2.  The distribution of plaques in the cerebrum in multiple sclerosis.

Authors:  B BROWNELL; J T HUGHES
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-11       Impact factor: 10.154

3.  Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue.

Authors:  J Newcombe; C P Hawkins; C L Henderson; H A Patel; M N Woodroofe; G M Hayes; M L Cuzner; D MacManus; E P du Boulay; W I McDonald
Journal:  Brain       Date:  1991-04       Impact factor: 13.501

4.  Magnetization transfer ratio histogram analysis of gray matter in relapsing-remitting multiple sclerosis.

Authors:  Y Ge; R I Grossman; J K Udupa; J S Babb; D L Kolson; J C McGowan
Journal:  AJNR Am J Neuroradiol       Date:  2001-03       Impact factor: 3.825

5.  Immunocytochemical method to identify myelin basic protein in oligodendroglia and myelin sheaths of the human nervous system.

Authors:  Y Itoyama; N H Sternberger; M W Kies; S R Cohen; E P Richardson; H Webster
Journal:  Ann Neurol       Date:  1980-02       Impact factor: 10.422

6.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

Authors:  J W Peterson; L Bö; S Mörk; A Chang; B D Trapp
Journal:  Ann Neurol       Date:  2001-09       Impact factor: 10.422

7.  Memory dysfunction in multiple sclerosis corresponds to juxtacortical lesion load on fast fluid-attenuated inversion-recovery MR images.

Authors:  D M Moriarty; A J Blackshaw; P R Talbot; H L Griffiths; J S Snowden; V F Hillier; S Capener; R D Laitt; A Jackson
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

8.  Grey matter abnormalities in multiple sclerosis: proton magnetic resonance spectroscopic imaging.

Authors:  R Sharma; P A Narayana; J S Wolinsky
Journal:  Mult Scler       Date:  2001-08       Impact factor: 6.312

9.  The normal appearing grey matter in primary progressive multiple sclerosis: a magnetisation transfer imaging study.

Authors:  J Dehmeshki; D T Chard; S M Leary; H C Watt; N C Silver; P S Tofts; A J Thompson; D H Miller
Journal:  J Neurol       Date:  2003-01       Impact factor: 4.849

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  121 in total

1.  Natalizumab prevents the accumulation of cortical lesions in relapsing remitting multiple sclerosis: a preliminary report.

Authors:  F Rinaldi; M Calabrese; D Seppi; M Puthenparampil; P Perini; P Gallo
Journal:  Neurol Sci       Date:  2011-01       Impact factor: 3.307

2.  Correlating quantitative MR imaging with histopathology in X-linked adrenoleukodystrophy.

Authors:  J P van der Voorn; P J W Pouwels; J M Powers; W Kamphorst; J-J Martin; D Troost; M D Spreeuwenberg; F Barkhof; M S van der Knaap
Journal:  AJNR Am J Neuroradiol       Date:  2011-01-27       Impact factor: 3.825

3.  Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis: a longitudinal OCT study.

Authors:  Anna M Pietroboni; Tiziana Carandini; Laura Dell'Arti; Francesca Bovis; Annalisa Colombi; Milena A De Riz; Elena Casazza; Elisa Scola; Chiara Fenoglio; Andrea Arighi; Giorgio G Fumagalli; Fabio Triulzi; Daniela Galimberti; Francesco Viola; Elio Scarpini
Journal:  Neurol Sci       Date:  2020-04-30       Impact factor: 3.307

4.  In vivo detection of cortical plaques by MR imaging in patients with multiple sclerosis.

Authors:  F Bagnato; J A Butman; S Gupta; M Calabrese; L Pezawas; J M Ohayon; F Tovar-Moll; M Riva; M M Cao; S L Talagala; H F McFarland
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

5.  Effects of formalin fixation on magnetic resonance indices in multiple sclerosis cortical gray matter.

Authors:  Klaus Schmierer; Janet R Thavarajah; Shu F An; Sebastian Brandner; David H Miller; Daniel J Tozer
Journal:  J Magn Reson Imaging       Date:  2010-11       Impact factor: 4.813

Review 6.  Causes, effects and connectivity changes in MS-related cognitive decline.

Authors:  Carolina de Medeiros Rimkus; Martijn D Steenwijk; Frederik Barkhof
Journal:  Dement Neuropsychol       Date:  2016 Jan-Mar

Review 7.  Grey matter damage in multiple sclerosis: a pathology perspective.

Authors:  Roel Klaver; Helga E De Vries; Geert J Schenk; Jeroen J G Geurts
Journal:  Prion       Date:  2013-01-01       Impact factor: 3.931

Review 8.  Grey matter lesions in MS: from histology to clinical implications.

Authors:  Massimiliano Calabrese; Alice Favaretto; Valeria Martini; Paolo Gallo
Journal:  Prion       Date:  2012-10-23       Impact factor: 3.931

Review 9.  Imaging as an Outcome Measure in Multiple Sclerosis.

Authors:  Daniel Ontaneda; Robert J Fox
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

10.  3D MPRAGE improves classification of cortical lesions in multiple sclerosis.

Authors:  F Nelson; A Poonawalla; P Hou; J S Wolinsky; P A Narayana
Journal:  Mult Scler       Date:  2008-11       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.